Potential role of ADAM (A Disintegrin And Metalloprotease) in malignant pleural mesothelioma resistance to chemotherapy.
M. Bellefroid (Liege, Belgium), C. Sépult (Liege, Belgium), C. Vanwinge (Liege, Belgium), A. Gillard (Liege, Belgium), B. Duysinx (Liege, Belgium), C. Poulet (Liege, Belgium), A. Debit (Liege, Belgium), A. Noel (Liege, Belgium), D. Cataldo (Liege, Belgium)
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Session: Novel directions in pleural disease: bench to bedside
Session type: E-poster session
Number: 1136
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bellefroid (Liege, Belgium), C. Sépult (Liege, Belgium), C. Vanwinge (Liege, Belgium), A. Gillard (Liege, Belgium), B. Duysinx (Liege, Belgium), C. Poulet (Liege, Belgium), A. Debit (Liege, Belgium), A. Noel (Liege, Belgium), D. Cataldo (Liege, Belgium). Potential role of ADAM (A Disintegrin And Metalloprotease) in malignant pleural mesothelioma resistance to chemotherapy.. 1136
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Expression of A D isintegrin a nd M etalloprotease (ADAM) enzymes in human squamous cell lung carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 704s Year: 2004
Expression of adamalysin proteases (A Disintegrin And Metalloprotease) and their inhibitors in sputum from asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
ADAM10 membrane-bound protease mediates malignant pleural mesothelioma invasiveness Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018
Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma Source: Eur Respir J, 51 (5) 1701610; 10.1183/13993003.01610-2017 Year: 2018
A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Source: Eur Respir J 2010; 36: 1099-1105 Year: 2010
Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) is a novel regulator of BPD Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Metalloproteinases, tissue inhibitors of metalloproteinases and TGF-β as predictors of pleura thickening in pleural tuberculosis Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions Source: Eur Respir J 2005; 25: 104-109 Year: 2005
Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM) Source: Eur Respir J 2004; 24: Suppl. 48, 81s Year: 2004
Multimodal therapy in malignant pleural mesothelioma (MPM) Source: Eur Respir J 2002; 20: Suppl. 38, 187s Year: 2002
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007
Over-expression of chloride intracellular channels (CLICs) 3 and 4 in malignant pleural mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013
Role of tumor derived versican in experimental malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Source: Eur Respir J 2012; 39: 677-684 Year: 2012
The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006
Targeting of CSF1R abrogates Lewis Lung adenocarcinoma-induced malignant pleural effusion Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018
The metallopeptidase neprilysin is a hypoxia-induced prognostic factor in lung adenocarcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008